Editorial commentary on “Gait phenotype in Batten disease: A marker of disease progression”
- 1 November 2021
- journal article
- editorial
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 35, A2
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Gait phenotype in Batten disease: A marker of disease progressionEuropean Journal of Paediatric Neurology, 2021
- A multimodal approach to identify clinically relevant biomarkers to comprehensively monitor disease progression in a mouse model of pediatric neurodegenerative diseaseProgress in Neurobiology, 2020
- Motor function impairment is an early sign of CLN3 diseaseNeurology, 2019
- Therapeutic landscape for Batten disease: current treatments and future prospectsNature Reviews Neurology, 2019
- An Adapted Clinical Measurement Tool for the Key Symptoms of CLN2 DiseaseJournal of Inborn Errors of Metabolism and Screening, 2018
- Analysis of large-scale whole exome sequencing data to determine the prevalence of genetically-distinct forms of neuronal ceroid lipofuscinosisGene, 2016